CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

BAL PHARMA LTD.

NSE : BALPHARMABSE : 524824ISIN CODE : INE083D01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE109.68-12.02 (-9.88 %)
PREV CLOSE () 121.70
OPEN PRICE () 119.99
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8758
TODAY'S LOW / HIGH ()109.53 119.99
52 WK LOW / HIGH ()76.3 157.9
NSE110.00-12.23 (-10.01 %)
PREV CLOSE() 122.23
OPEN PRICE () 118.01
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 110.00 (3297)
VOLUME 206653
TODAY'S LOW / HIGH() 110.00 118.01
52 WK LOW / HIGH ()78.06 157.98
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987

Management Info :

- Chairman Shailesh Siroya - Managing Director

Registered Office :

Address : #21&22, Bommasandra Industrial Area,Anekal Taluk, ,
Bengaluru,
Karnataka-560099

Phone : 080 41570811 / 13 / 19

Website : www.balpharma.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C-101, 1st Floor,247 Park, Lal Bahadur Shastri Marg,Vikhroli West,Mumbai
Listing : BSE, NSE
NEWS
05Nov Bal Pharma informs about board meeting
Bal Pharma has informed that the meeting of the Board of Directors of th..
30Aug Bal Pharma informs about annual report
Bal Pharma has informed that it enclosed the unabridged Annual Report of..
04Apr BAL Pharma informs about compliance ce
BAL Pharma has submitted confirmation as prescribed under the Regulation..
02Apr Bal Pharma informs about non-applicabi
Pursuant to SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 da..
14Feb Bal Pharma informs about press release
Bal Pharma has informed that it enclosed copies of the newspaper adverti..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit11.5499999999999102.72
Gross Profit 12.0299999999999 121.06
Operating Profit 85.4599999999999357.93
Net Sales 728.853385.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Everest Organics (BSE)
 299.65 (8.88%)
M.Cap ( in Cr)
290.98
Kilitch Drugs(India) (BSE)
 350.15 (3.79%)
M.Cap ( in Cr)
563.12
Makers Laboratories (BSE)
 139.95 (3.67%)
M.Cap ( in Cr)
82.58
Valiant Laboratories (BSE)
 93.40 (4.24%)
M.Cap ( in Cr)
405.82
Unick Fix-A-Form (BSE)
 65.95 (4.38%)
M.Cap ( in Cr)
36.17
Shareholding Pattern
PROMOTERS 50.86%
NON-INSTITUTION 49%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73137.90-2226.79 (-2.95%)
NIFTY22161.60-742.85 (-3.24%)
Dow Jones 37965.60-349.26 (-0.91%)
Nasdaq 15603.2615.47 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI